Clinical trial

A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)

NCT05953740

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention MK-5720 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo to MK-5720 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention MK-8189 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo to MK-8189 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-09-15

PhasePHASE1

Conditions

Schizophreniaverified · MONDO: schizophrenia

Interventions

MK-5720DRUG

Placebo to MK-5720DRUG

MK-8189DRUG

Placebo to MK-8189DRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Mapped research locations

HollywoodFlorida, United States1 GlendaleCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05953740 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.